Growth hormone releasing hormone reverses endotoxin-induced localized inflammatory hyperalgesia without reducing the upregulated cytokines, nerve growth factor and gelatinase activity

Rabih S. Talhouk, Nayef E. Saadé, Ghassan Mouneimne, Cynthia A. Masaad, Bared Safieh-Garabedian

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

During inflammatory processes, the hypothalamic-pituitary axis is activated which can subsequently result in analgesia. For example, hypothalamic corticotrophin-releasing hormone (CRH) that is released during such activation has been attributed with analgesic actions. It is believed that the somatotrophic axis is also activated during inflammation. The aim of this study was to determine the analgesic actions of growth hormone-releasing hormone (GHRH), in a rat model of localized inflammatory hyperalgesia, induced by intraplantar (i.pl.) endotoxin (ET) injections. Pretreatment with intraperitoneal (i.p.) injections of GHRH (2, 5, 10 μg kg-1) 30 min before i.pl. ET injection (1.25 μg in 50 μl saline) prevented, in a dose-dependent manner, both mechanical hyperalgesia determined by the paw pressure (PP) test and thermal hyperalgesia determined by the hot plate (HP) and paw immersion (PI) tests. Pretreatment with GHRH had no significant effect on the elevated levels of the inflammatory mediators, interleukin (IL)-1β, tumor necrosis factor (TNF)-α, IL-6 and nerve growth factor (NGF) due to i.pl. ET injection. No significant effect was obtained by pretreatment with GHRH, on the increased expression of gelatinase B due to ET injection. In conclusion, GHRH reverses inflammatory hyperalgesia in the rat without affecting the upregulated inflammatory mediators and these actions may be clinically important.

Original languageEnglish (US)
Pages (from-to)625-631
Number of pages7
JournalProgress in Neuro-Psychopharmacology and Biological Psychiatry
Volume28
Issue number4
DOIs
StatePublished - Jul 2004
Externally publishedYes

Fingerprint

Growth Hormone-Releasing Hormone
Gelatinases
Hyperalgesia
Nerve Growth Factor
Endotoxins
Cytokines
Injections
Analgesics
Pituitary Hormone-Releasing Hormones
Corticotropin-Releasing Hormone
Matrix Metalloproteinase 9
Immersion
Intraperitoneal Injections
Interleukin-1
Analgesia
Interleukin-6
Tumor Necrosis Factor-alpha
Inflammation
Pressure

Keywords

  • central nervous system
  • CNS
  • corticotrophin-releasing hormone
  • CRH
  • Cytokines
  • ELISA
  • endotoxin
  • Enzyme-Linked Immunosorbent Assay
  • ET
  • Gelatinase B
  • GH
  • GHRH
  • growth hormone
  • growth hormone-releasing hormone
  • hot plate
  • HP
  • HPA
  • Hyperalgesia
  • Inflammation
  • NGF

ASJC Scopus subject areas

  • Biological Psychiatry
  • Pharmacology

Cite this

Growth hormone releasing hormone reverses endotoxin-induced localized inflammatory hyperalgesia without reducing the upregulated cytokines, nerve growth factor and gelatinase activity. / Talhouk, Rabih S.; Saadé, Nayef E.; Mouneimne, Ghassan; Masaad, Cynthia A.; Safieh-Garabedian, Bared.

In: Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 28, No. 4, 07.2004, p. 625-631.

Research output: Contribution to journalArticle

@article{8d880a2956e742acb250438b4677c528,
title = "Growth hormone releasing hormone reverses endotoxin-induced localized inflammatory hyperalgesia without reducing the upregulated cytokines, nerve growth factor and gelatinase activity",
abstract = "During inflammatory processes, the hypothalamic-pituitary axis is activated which can subsequently result in analgesia. For example, hypothalamic corticotrophin-releasing hormone (CRH) that is released during such activation has been attributed with analgesic actions. It is believed that the somatotrophic axis is also activated during inflammation. The aim of this study was to determine the analgesic actions of growth hormone-releasing hormone (GHRH), in a rat model of localized inflammatory hyperalgesia, induced by intraplantar (i.pl.) endotoxin (ET) injections. Pretreatment with intraperitoneal (i.p.) injections of GHRH (2, 5, 10 μg kg-1) 30 min before i.pl. ET injection (1.25 μg in 50 μl saline) prevented, in a dose-dependent manner, both mechanical hyperalgesia determined by the paw pressure (PP) test and thermal hyperalgesia determined by the hot plate (HP) and paw immersion (PI) tests. Pretreatment with GHRH had no significant effect on the elevated levels of the inflammatory mediators, interleukin (IL)-1β, tumor necrosis factor (TNF)-α, IL-6 and nerve growth factor (NGF) due to i.pl. ET injection. No significant effect was obtained by pretreatment with GHRH, on the increased expression of gelatinase B due to ET injection. In conclusion, GHRH reverses inflammatory hyperalgesia in the rat without affecting the upregulated inflammatory mediators and these actions may be clinically important.",
keywords = "central nervous system, CNS, corticotrophin-releasing hormone, CRH, Cytokines, ELISA, endotoxin, Enzyme-Linked Immunosorbent Assay, ET, Gelatinase B, GH, GHRH, growth hormone, growth hormone-releasing hormone, hot plate, HP, HPA, Hyperalgesia, Inflammation, NGF",
author = "Talhouk, {Rabih S.} and Saad{\'e}, {Nayef E.} and Ghassan Mouneimne and Masaad, {Cynthia A.} and Bared Safieh-Garabedian",
year = "2004",
month = "7",
doi = "10.1016/j.pnpbp.2004.01.012",
language = "English (US)",
volume = "28",
pages = "625--631",
journal = "Progress in Neuro-Psychopharmacology and Biological Psychiatry",
issn = "0278-5846",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Growth hormone releasing hormone reverses endotoxin-induced localized inflammatory hyperalgesia without reducing the upregulated cytokines, nerve growth factor and gelatinase activity

AU - Talhouk, Rabih S.

AU - Saadé, Nayef E.

AU - Mouneimne, Ghassan

AU - Masaad, Cynthia A.

AU - Safieh-Garabedian, Bared

PY - 2004/7

Y1 - 2004/7

N2 - During inflammatory processes, the hypothalamic-pituitary axis is activated which can subsequently result in analgesia. For example, hypothalamic corticotrophin-releasing hormone (CRH) that is released during such activation has been attributed with analgesic actions. It is believed that the somatotrophic axis is also activated during inflammation. The aim of this study was to determine the analgesic actions of growth hormone-releasing hormone (GHRH), in a rat model of localized inflammatory hyperalgesia, induced by intraplantar (i.pl.) endotoxin (ET) injections. Pretreatment with intraperitoneal (i.p.) injections of GHRH (2, 5, 10 μg kg-1) 30 min before i.pl. ET injection (1.25 μg in 50 μl saline) prevented, in a dose-dependent manner, both mechanical hyperalgesia determined by the paw pressure (PP) test and thermal hyperalgesia determined by the hot plate (HP) and paw immersion (PI) tests. Pretreatment with GHRH had no significant effect on the elevated levels of the inflammatory mediators, interleukin (IL)-1β, tumor necrosis factor (TNF)-α, IL-6 and nerve growth factor (NGF) due to i.pl. ET injection. No significant effect was obtained by pretreatment with GHRH, on the increased expression of gelatinase B due to ET injection. In conclusion, GHRH reverses inflammatory hyperalgesia in the rat without affecting the upregulated inflammatory mediators and these actions may be clinically important.

AB - During inflammatory processes, the hypothalamic-pituitary axis is activated which can subsequently result in analgesia. For example, hypothalamic corticotrophin-releasing hormone (CRH) that is released during such activation has been attributed with analgesic actions. It is believed that the somatotrophic axis is also activated during inflammation. The aim of this study was to determine the analgesic actions of growth hormone-releasing hormone (GHRH), in a rat model of localized inflammatory hyperalgesia, induced by intraplantar (i.pl.) endotoxin (ET) injections. Pretreatment with intraperitoneal (i.p.) injections of GHRH (2, 5, 10 μg kg-1) 30 min before i.pl. ET injection (1.25 μg in 50 μl saline) prevented, in a dose-dependent manner, both mechanical hyperalgesia determined by the paw pressure (PP) test and thermal hyperalgesia determined by the hot plate (HP) and paw immersion (PI) tests. Pretreatment with GHRH had no significant effect on the elevated levels of the inflammatory mediators, interleukin (IL)-1β, tumor necrosis factor (TNF)-α, IL-6 and nerve growth factor (NGF) due to i.pl. ET injection. No significant effect was obtained by pretreatment with GHRH, on the increased expression of gelatinase B due to ET injection. In conclusion, GHRH reverses inflammatory hyperalgesia in the rat without affecting the upregulated inflammatory mediators and these actions may be clinically important.

KW - central nervous system

KW - CNS

KW - corticotrophin-releasing hormone

KW - CRH

KW - Cytokines

KW - ELISA

KW - endotoxin

KW - Enzyme-Linked Immunosorbent Assay

KW - ET

KW - Gelatinase B

KW - GH

KW - GHRH

KW - growth hormone

KW - growth hormone-releasing hormone

KW - hot plate

KW - HP

KW - HPA

KW - Hyperalgesia

KW - Inflammation

KW - NGF

UR - http://www.scopus.com/inward/record.url?scp=3342876740&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3342876740&partnerID=8YFLogxK

U2 - 10.1016/j.pnpbp.2004.01.012

DO - 10.1016/j.pnpbp.2004.01.012

M3 - Article

VL - 28

SP - 625

EP - 631

JO - Progress in Neuro-Psychopharmacology and Biological Psychiatry

JF - Progress in Neuro-Psychopharmacology and Biological Psychiatry

SN - 0278-5846

IS - 4

ER -